Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resistant Potato Starch for Aromatase Inhibitor-Associated Musculoskeletal Symptom Prevention
NCT07443943Phase 2Recruiting
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of resistant potato starch in Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS), sponsored by University of Michigan Rogel Cancer Center. Started Apr 2026; status: recruiting.
02
Drugs
resistant potato starch
03
Conditions
Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)
Beyond the preview
Go deeper on NCT07443943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07443943.